Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial

DOI Full Paper Access

126

Citations

20

References

2020

Year

Judith Absalon, Nathan Segall, Stan L. Block

The Lancet Infectious Diseases

VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentImmunologyInfection ControlDose-escalation TrialMedicineVaccine ResearchClinical MicrobiologyNon-pregnant Adults

References

	Year	Citations

Page 1